Navigation Links
Prostate cancer gets around hormone therapy by activating a survival cell signaling pathway
Date:6/14/2011

Cancer is crafty. When one avenue driving its growth is blocked by drugs targeting that path, the malignancy often creates a detour, finding an alternative route to get around the roadblock.

In a study at UCLA's Jonsson Comprehensive Cancer Center, researchers found that when a common type of prostate cancer was treated with conventional hormone ablation therapy blocking androgen production or androgen receptor (AR) function which drives growth of the tumor the cancer was able to adapt and compensate by activating a survival cell signaling pathway, effectively circumventing the roadblock put up by this treatment.

The findings could have important clinical implications as this type of prostate cancer, in which the PTEN tumor suppressor gene is inactivated, accounts for about 40 to 50 percent of primary prostate cancers and 70 to 90 percent of cancers that become resistant to hormone therapy, called castration resistant prostate cancers. Based on this study, these prostate cancers could be more effectively treated using a combination of drugs that target the AR cell signaling pathway and the compensating survival pathway, called the PI3K/AKT/mTOR pathway, said study senior author Dr. Hong Wu, a professor of molecular and medical pharmacology and a Jonsson Cancer Center researcher.

The study appears in the June 14, 2011 of the peer-reviewed journal Cancer Cell.

"The most significant take home message from this study is that certain prostate cancers can resist androgen deprivation therapy by activating an alternate pathway to drive its growth," Wu said. "We found that these two pathways are talking to each other, almost like regulatory circuitry, and helping each other get around attempts to kill the cancer. When we suppress one of these pathways, it essentially feeds the other."

Wu characterized the findings as surprising. What they discovered, she said, bucked conventional wisdom about the way PTEN negativ
'/>"/>

Contact: Kim Irwin
kirwin@mednet.ucla.edu
310-206-2805
University of California - Los Angeles Health Sciences
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Drugs for Enlarged Prostate May Raise Risk of Aggressive Cancer
2. Drug shows promise in prostate cancer spread to bone
3. Jury Still Out on Radiation for Early Prostate Cancer
4. Targeted cancer therapy kills prostate tumor cells
5. Hormone deprivation therapy for prostate cancer may raise diabetes risk
6. ASCO: Experimental vaccine made from frozen immune cells shows promise for prostate cancer patients
7. Antifungal drug delays need for chemo in advanced prostate cancer
8. Higher doses of radiation in fewer treatments proved safe, effective for low-risk prostate cancer
9. IMRT cuts GI side effects from prostate cancer in half vs. 3D-CRT
10. New Drug Extends Survival for Men With Advanced Prostate Cancer
11. New drug treatment extends lives of men with prostate cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... (PRWEB) October 22, 2014 Isabel ... of Allied Health Professions (ASAHP) Conference on October 22-24 ... CEO will participate in a panel discussion on Technology ... , Isabel Healthcare provides a diagnostic decision support tool ... the diagnosis skills of students and clinical learners. The ...
(Date:10/22/2014)... The Louis W. Sullivan ... to distribute health information technology innovation to transform ... the development of six key guiding principles of ... healthcare. These are an expansion of the Institute ... that is respectful of and responsive to individual ...
(Date:10/22/2014)... 2014 Healthcare professionals who are ... education at home or on-the-go via laptops, tablets ... brand new, premium Seminar-on-Demand CE courses. The new ... 2,000 hours of CE course offerings, ... experience. With such a diverse library, there’s something ...
(Date:10/22/2014)... 22, 2014 Akeso Biomedical, Inc. ... the treatment of bacterial infections, microbial biofilms, and chronic ... its board of directors. , Dr. Sinskey ... at The Massachusetts Institute of Technology, or MIT. He ... 1968. Dr. Sinskey also holds positions as Co-Director of ...
(Date:10/22/2014)... Salamon HealthDay Reporter TUESDAY, ... conventional in vitro fertilization (IVF) -- the incubation of embryos ... a device inside the vagina, new research suggests. Scientists ... called an INVOcell, might sharply cut costs for pricey IVF ... more accessible to those who don,t live near big-city assisted ...
Breaking Medicine News(10 mins):Health News:Isabel Healthcare to Participate in The Association of Schools of Allied Health Professions (ASAHP) 2014 Conference 2Health News:The Sullivan Institute for Healthcare Innovation Announces Release of Guiding Principles for Patient Experience-Centered Care 2Health News:Top Provider of Continuing Education at Home Releases 20 New Online Courses 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4
... 7 The Generic Pharmaceutical Association (GPhA) will discuss the ... leading healthcare market intelligence company, revealing that generic pharmaceutical utilization ... care system in the last decade., What: ... $734, ...
... Edward Downs has been named chief executive officer of Renaissance Hospital ... ... Houston, TX (PRWEB) May 7, 2009 -- Renaissance Healthcare ... executive officer of Renaissance Hospital Dallas. The appointment was effective May ...
... and Payroll Solutions Leader Introduces Industry-Pioneering Application , ... ... HRO®, a leader in human resources and payroll solutions, announces ... is a bold fusion of the company’s legacy GenevaPlus and ...
... & Sportsclub Association (IHRSA) and fitness professionals across ... meet with their Congressional members, asking for their ... barriers from exercise, and to reward Americans for ... Annual IHRSA Summit for a Healthier America, fitness ...
... other common factors in home health care can make ... used discount medical supplies. TheMedicalSupplyDepot.com announces the new Auto ... care individuals, set up their orders ahead of time ... skin care, incontinence or wound care items they need ...
... Pixantrone Named-Patient Program Initiated in Europe SEATTLE, May 7 ... reported recent accomplishments and financial results for the quarter ... half of 2009 was to initiate and complete the ... in our cost cutting efforts and raised much needed ...
Cached Medicine News:Health News:Edward Downs Named CEO of Renaissance Hospital Dallas 2Health News:Unicorn HRO Unveils iCON 2Health News:Fitness Industry Leaders Across the Nation Gather on Capitol Hill to Campaign for a Healthier America 2Health News:Fitness Industry Leaders Across the Nation Gather on Capitol Hill to Campaign for a Healthier America 3Health News:Fitness Industry Leaders Across the Nation Gather on Capitol Hill to Campaign for a Healthier America 4Health News:Home Health Care Supplies 'Order Themselves' with New Auto Reorder from TheMedicalSupplyDepot.com 2Health News:Home Health Care Supplies 'Order Themselves' with New Auto Reorder from TheMedicalSupplyDepot.com 3Health News:Cell Therapeutics Reports 76% Decrease in First Quarter 2009 Net Loss Attributable to Common Shareholders; Completion of Pixantrone NDA Submission on Track for Second Quarter 2009 2Health News:Cell Therapeutics Reports 76% Decrease in First Quarter 2009 Net Loss Attributable to Common Shareholders; Completion of Pixantrone NDA Submission on Track for Second Quarter 2009 3Health News:Cell Therapeutics Reports 76% Decrease in First Quarter 2009 Net Loss Attributable to Common Shareholders; Completion of Pixantrone NDA Submission on Track for Second Quarter 2009 4Health News:Cell Therapeutics Reports 76% Decrease in First Quarter 2009 Net Loss Attributable to Common Shareholders; Completion of Pixantrone NDA Submission on Track for Second Quarter 2009 5Health News:Cell Therapeutics Reports 76% Decrease in First Quarter 2009 Net Loss Attributable to Common Shareholders; Completion of Pixantrone NDA Submission on Track for Second Quarter 2009 6
(Date:10/22/2014)... -- Influenza will affect as many as 200,000 people this ... States as high as 49,000 people.  The main ... person to person in respiratory droplets of coughs and sneezes. ... but kills much fewer people each year than the Flu. ... including sweat, saliva, blood and other bodily fluids. The Ebola ...
(Date:10/22/2014)... , Oct. 22, 2014 WHEN: Wednesday, ... Online, complimentary registration available at: http://bit.ly/1yStiU9 ... Archana Vidyasekar and Visionary Innovation Research Group ... wireless electricity, self-assembling materials, nanobots and flexible ... which will transform our lives in the ...
(Date:10/22/2014)...  Recently published clinical studies of Stretta for gastroesophageal ... of evidence. This data has led to significantly expanded ... for sufferers of refractory GERD. The ... therapy as a safe and effective GERD treatment has ... to nearly 50 million Americans. The new clinical studies ...
Breaking Medicine Technology:WholeHealth Products is proud to be releasing its Influenza A and B combo test, on the heels of the announcing of its phase 2 completion of the Rapid Ebola Test 2Futuristic Technologies That Will Transform Our World Beyond 2030 2Futuristic Technologies That Will Transform Our World Beyond 2030 3Futuristic Technologies That Will Transform Our World Beyond 2030 4Recent Clinical Study Data Confirms Efficacy of Stretta Therapy - Spurs Additional Insurance Coverage and Financing Round 2
... 12, 2007: Progen Industries Limited,(ASX: PGL; NASDAQ: PGLA) is ... data has been accepted for late breaking news,presentation by ... Progen will also be presenting the results of this ... (AACR),Annual Meeting 2007. , ,In expectation of having ...
... Good Safety Profile and Excellent,Pharmacokinetic Properties -, RESEARCH ... BioPharma, Inc., a clinical stage company developing and,commercializing ... today announced top-line results from a Phase I,clinical ... treatment,of depression and anxiety. In this study, Tyrima ...
Cached Medicine Technology:PI-88 Data to be Presented at Key International Conferences 2PI-88 Data to be Presented at Key International Conferences 3CeNeRx BioPharma Announces Positive Phase I Results in First Human,Trial of Third Generation RIMA Antidepressant 2CeNeRx BioPharma Announces Positive Phase I Results in First Human,Trial of Third Generation RIMA Antidepressant 3
... to order tips. Each box contains 10,000 ... available in easy-to-open, re-sealable Bulk Packs of ... sealed with a tamper-proof strip which can ... Gilsons Diamond Tips. Bulk Packs are closed ...
... Theken eDISC is a revolutionary advancement in ... assess and manage their patients. The eDISC's ... the eDISC from 1st and 2nd generation ... loads of the lumbar spine, the eDISC ...
This 10 L tip was designed for the Pipetman P-2 and P-10. Its MicroPoint design and 2 L reference mark make it ideal for low volume pipetting....
... Tips - 2l - 200l. Reduces DNA and ... packaged completely by automation. RNAse & DNAse free. ... and 10 racks/cs. AVR2 is the Cell Rack ... the Stacked Rack packaged 96 tips/rack and 10 ...
Medicine Products: